Search

everythinglearnresearchcommunity

for

Search:↓

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

The plant extract and minoxidil both reduce hair loss by lowering specific gene expressions.

SOD1 and KL are promising targets for new hair loss treatments.

DEC cells show promise as a safe and effective treatment for Duchenne muscular dystrophy.

Metformin increases FSH levels in PCOS, and KISS1 gene variations may influence PCOS development.

Liposomes show promise for delivering CRISPR for gene editing but face challenges like delivery efficiency and safety concerns.

RCS-01 cell therapy is safe and improves skin gene expression.

A newborn with severe low blood sugar due to a genetic issue needed major surgery after standard treatments failed.

Researchers found certain genes are overactive and others are underactive in men with early balding, which could help create new treatments.

Avicennia marina extract and avicequinone C can potentially promote hair growth and treat hair loss by interfering with hair loss mechanisms and boosting growth factors.

RCS-01 therapy is safe and may improve skin structure by affecting gene expression.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

The WNT signaling pathway is important in many diseases and targeting it could offer new treatments.

Certain blood miRNAs are linked to severe alopecia areata and could lead to new treatments.

DNA methylation changes in women with PCOS could be used as disease markers and suggest new treatment targets.

Patients with the same genetic mutation for vitamin D-resistant rickets showed different symptoms but all improved with treatment except for hair loss.

Histone demethylases play a key role in the development of many diseases and may be targets for treatment.

Obstructive sleep apnea can be hereditary and linked to a genetic mutation in the COL1A2 gene.

An extremely low-birthweight infant had a rare genetic skin disease and died despite treatment.

Blocking the HEDGEHOG-GLI1 pathway can reduce keloid growth and may be a potential treatment.

There is no cure for myotonic dystrophy type 1, so treatment focuses on managing symptoms and complications.

Ultrasound can improve targeted drug delivery, making treatments more effective with fewer side effects.

A Chinese man with KID syndrome had a new mutation in the GJB2 gene.

A man with a rare lung-focused form of hypereosinophilic syndrome improved with steroid treatment.

Alopecia and acne in women are complex conditions needing coordinated care and personalized treatment.

Hidradenitis Suppurativa has genetic links, with certain gene mutations more common in patients and a third of cases having a family history.

Thymosin beta 4 protects cells from damage by blocking a harmful microRNA and boosting a protective gene.

Melanoma risk tools need improvement, a gene mutation causes a hair disorder that might be treated by managing cell stress, a potential therapy for a skin-ear disorder involves blocking cell channels, skin wrinkling may indicate lung aging regardless of smoking, and oxidative stress might contribute to common baldness.

Melanoma risk tools need improvement, certain gene mutations cause skin diseases and could be treated by targeting those mutations, skin wrinkling may relate to lung aging due to genetic factors, and oxidative stress affects hair loss but can be reduced in low oxygen.

Oestrogen and thyrotropin-releasing hormone affect prolactin and its receptor in human skin and hair, suggesting new treatment options for related conditions.